AKRO - Akero Therapeutics, Inc. Profit before interest, taxes and amortization
Akero Therapeutics (AKRO) volatility is driven by the expansion of its flagship peptide for MASH therapy, while the net operating income before depreciation on GURU.Markets reflects business dynamics where the value of 0.00 serves as the current metric. Stability will be ensured by mass insurance reimbursement for innovations in liver treatment, and independent development without corporate mergers will minimize external risks.
Summary analytical data breakdowns for Akero (AKRO)
- current quotes and average value forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
Debt to Equity Akero Therapeutics|AKRO - Long-Term Debt to Equity|Current Liabilities to Capital Akero Therapeutics, Inc.|AKRO - Company Debts|Debt to Book Capitalization Ratio Akero Therapeutics|AKRO - Company Long-Term Debts|Short-Term Debt Volume Akero Therapeutics|Interim Coverage Ratio akerotx.com
- financial results and valuation multiples details:
AKRO - Company Net Income|Future Profit Akero Therapeutics|AKRO - P/E Multiple|Forward P/E Multiple akerotx.com|AKRO - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Akero Therapeutics|AKRO - Operating profit EBITDA|Net earnings per one share for the last twelve months Akero Therapeutics|AKRO - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months akerotx.com|AKRO - Earnings per share growth in current year|Expected net earnings per share growth next year Akero Therapeutics
- sales revenue and business income indicators:
Analysis of all company metrics:Akero Corp (AKRO)
Absolute operating profit in cash captures the net cash flow from operating activities before depreciation and taxes, reflecting the efficiency of internal resource management. The current operating profit in cash at 0.00 confirms the R&D stage for Akero Therapeutics (AKRO), as the absence of commercial sales and the anticipation of Phase III trial results turn this metric into an indicator of the capital burn rate.
Who Akero Therapeutics competes with
ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|MTSR: Company profit before taxes, interest and amortization|MLTX (MoonLake Pharma) - Operating profit EBITDA|Operating profit EBITDA Crinetics Corp|Operating profit EBITDA NAMS|Profit before payment of interest, taxes and amortization SLNO (soleno.life)|Profit before payment of interest, taxes and amortization Amicus Therapeutics, Inc. FOLD|89bio Inc (ETNB) - Profit before interest, taxes and amortization|AGIO - Profit before payment of interest, taxes and amortization|GPCR: Profit before payment of interest, taxes and amortization|MDXG: Operating profit EBITDA|RZLT - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Lexicon Pharmaceuticals, Inc.|MBX Biosciences, Inc. (MBX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Altimmune Corp (ALT)|Operating profit before deduction of amortization Aardvark Pharma AARD|Operating profit EBITDA SGMT (Sagimet Biosciences)|Operating profit EBITDA bioagelabs.com BIOA|BMEA - Profit before payment of interest, taxes and amortization|QNCX - Operating profit EBITDA|GUTS: Operating profit EBITDA|Profit before interest, taxes and amortization vTv Therapeutics (VTVT)|Profit before payment of interest, taxes and amortization Agape ATP Corp|PLUR: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Synlogic, Inc. (SYBX)|LPCN - Profit before interest, taxes and amortization|Matinas BioPharma Holdings - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SPRB|GLTO: Operating profit before deduction of amortization|carmellrx.com - Company profit before taxes, interest and amortization|LUMO: Operating profit EBITDA|Organovo Holdings - Income before deduction of interest, taxes and amortization|RDUS (Radius Health) - Operating profit EBITDA
